JP2024507118A5 - - Google Patents
Info
- Publication number
- JP2024507118A5 JP2024507118A5 JP2023547794A JP2023547794A JP2024507118A5 JP 2024507118 A5 JP2024507118 A5 JP 2024507118A5 JP 2023547794 A JP2023547794 A JP 2023547794A JP 2023547794 A JP2023547794 A JP 2023547794A JP 2024507118 A5 JP2024507118 A5 JP 2024507118A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163148543P | 2021-02-11 | 2021-02-11 | |
| US63/148,543 | 2021-02-11 | ||
| PCT/US2022/016229 WO2022174114A1 (en) | 2021-02-11 | 2022-02-11 | Anti-transferrin receptor fusion proteins and methods of use thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024507118A JP2024507118A (ja) | 2024-02-16 |
| JPWO2022174114A5 JPWO2022174114A5 (https=) | 2025-02-18 |
| JP2024507118A5 true JP2024507118A5 (https=) | 2025-02-18 |
Family
ID=82837358
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023547794A Pending JP2024507118A (ja) | 2021-02-11 | 2022-02-11 | 抗トランスフェリン受容体融合タンパク質及びその使用方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (3) | US20240148866A1 (https=) |
| EP (1) | EP4291246A4 (https=) |
| JP (1) | JP2024507118A (https=) |
| CN (1) | CN116997364A (https=) |
| MA (1) | MA71665A (https=) |
| WO (1) | WO2022174114A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20260015409A1 (en) * | 2022-09-20 | 2026-01-15 | Dana-Farber Cancer Institute, Inc. | Receptor-mediated endocytosis for targeted internalization and degradation of membrane proteins and cargos |
| AR131281A1 (es) | 2022-12-05 | 2025-03-05 | Sanofi Sa | Proteínas de unión al receptor de transferrina |
| AU2024299328A1 (en) | 2023-07-21 | 2026-01-22 | Marrow Therapeutics, Inc. | Hematopoietic cell targeting conjugates and related methods |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003032913A2 (en) * | 2001-10-16 | 2003-04-24 | Symbiontics Inc. | Methods and compositions for targeting proteins across the blood brain barrier |
| BR112014000352A2 (pt) * | 2011-07-08 | 2017-02-14 | Merck Sharp & Dohe Corp | método de purificar uma proteína de fusão-fc, proteínas de fusão contendo fc purificada, tnfr:fc purificada, e tnfr:fc elevadamente purificada |
| US9994641B2 (en) * | 2013-12-25 | 2018-06-12 | Jcr Pharmaceuticals Co., Ltd. | Anti-human transferrin receptor antibody that passes through blood-brain barrier |
| TWI769982B (zh) * | 2015-06-24 | 2022-07-11 | 日商Ｊｃｒ製藥股份有限公司 | 通過血腦障壁之抗人類運鐵蛋白受體抗體 |
| AU2017316955B2 (en) * | 2016-08-25 | 2022-03-03 | Jcr Pharmaceuticals Co., Ltd. | Method for producing antibody fusion protein |
| TWI761413B (zh) * | 2016-12-26 | 2022-04-21 | 日商Ｊｃｒ製藥股份有限公司 | 通過血腦障壁之新穎抗人類運鐵蛋白受體抗體 |
| US10940185B2 (en) * | 2016-12-28 | 2021-03-09 | Jcr Pharmaceuticals Co., Ltd. | Lyophilized preparation |
| AU2018345303B2 (en) * | 2017-10-02 | 2025-09-18 | Denali Therapeutics Inc. | Fusion proteins comprising enzyme replacement therapy enzymes |
| JP7458404B2 (ja) * | 2018-12-20 | 2024-03-29 | アーマジェン・インコーポレイテッド | イズロン酸－２－スルファターゼ免疫グロブリン融合タンパク質の精製 |
-
2022
- 2022-02-11 EP EP22753465.8A patent/EP4291246A4/en active Pending
- 2022-02-11 JP JP2023547794A patent/JP2024507118A/ja active Pending
- 2022-02-11 CN CN202280022750.1A patent/CN116997364A/zh active Pending
- 2022-02-11 WO PCT/US2022/016229 patent/WO2022174114A1/en not_active Ceased
- 2022-02-11 US US18/276,823 patent/US20240148866A1/en active Pending
- 2022-02-11 MA MA71665A patent/MA71665A/fr unknown
-
2025
- 2025-08-19 US US19/304,112 patent/US20250387477A1/en active Pending
- 2025-08-19 US US19/304,134 patent/US20250367284A1/en active Pending